Giovanni Candiano Selected Research

Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)

10/2021	Proteomic profile of mesothelial exosomes isolated from peritoneal dialysis effluent of children with focal segmental glomerulosclerosis.
1/2017	Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.
5/2011	Analysis of the oxido-redox status of plasma proteins. Technology advances for clinical applications.
1/2009	New iodo-acetamido cyanines for labeling cysteine thiol residues. A strategy for evaluating plasma proteins and their oxido-redox status.
7/2008	Proteins and protein fragments in nephrotic syndrome: Clusters, specificity and mechanisms.
1/2008	Proteomics of plasma and urine in primary nephrotic syndrome in children.
11/2007	Protracted remission of proteinuria after combined therapy with plasmapheresis and anti-CD20 antibodies/cyclophosphamide in a child with oligoclonal IgM and glomerulosclerosis.
3/2007	Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin.
7/2006	Transitions of serum albumin in patients with glomerulosclerosis 'in vivo' characterization by electrophoretic titration curves.
7/2005	Direct effect of plasma permeability factors from patients with idiopatic FSGS on nephrin and podocin expression in human podocytes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giovanni Candiano Research Topics

Disease

16	Proteinuria 01/2021 - 12/2001
15	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2021 - 12/2001
15	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 10/2021 - 01/2001
13	Membranous Glomerulonephritis (Membranous Nephropathy) 12/2020 - 12/2002
11	Lupus Nephritis 12/2021 - 03/2010
8	Neoplasms (Cancer) 12/2021 - 05/2005
7	Glomerulonephritis 12/2021 - 05/2006
6	Chronic Kidney Failure (Chronic Renal Failure) 05/2022 - 01/2001
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2017
5	Medullary Sponge Kidney 06/2022 - 01/2017
5	Infections 05/2022 - 01/2019
5	Rheumatoid Arthritis 12/2021 - 08/2015
5	Inflammation (Inflammations) 11/2021 - 11/2005
5	Fibrosis (Cirrhosis) 01/2016 - 08/2004
4	Nephrolithiasis 01/2021 - 01/2017
3	Vasculitis (Vasculitides) 01/2020 - 01/2017
2	Premature Birth (Birth, Premature) 11/2021 - 05/2016
2	Sclerosis 10/2021 - 12/2002
2	Astrocytoma (Pilocytic Astrocytoma) 01/2021 - 05/2005
2	Kidney Diseases (Kidney Disease) 10/2020 - 01/2016
2	Hypoxia (Hypoxemia) 01/2018 - 07/2013
2	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 01/2015
2	IGA Glomerulonephritis (IGA Nephropathy) 07/2013 - 09/2012
2	Immune System Diseases (Immune Disorders) 02/2011 - 07/2005
2	Hypercholesterolemia 02/2003 - 12/2002
1	Rupture 11/2021
1	Preterm Premature Rupture of the Membranes 11/2021
1	Peritoneal Fibrosis 10/2021
1	Glioma (Gliomas) 01/2021
1	Medulloblastoma 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Premature Obstetric Labor (Premature Labor) 01/2020
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Ischemia 01/2018
1	Hyperoxia 01/2018
1	Cysts 01/2017
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2017
1	Mucopolysaccharidosis II (Hunter Syndrome) 01/2017
1	Wounds and Injuries (Trauma) 05/2016
1	Urinoma 03/2016
1	Dent Disease 01/2016

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 11/2021 - 02/2002
15	AntibodiesIBA 10/2021 - 11/2007
11	Biomarkers (Surrogate Marker)IBA 11/2021 - 07/2008
9	AutoantibodiesIBA 12/2021 - 09/2012
9	AlbuminsIBA 12/2013 - 01/2001
8	SteroidsIBA 10/2021 - 12/2001
7	Immunoglobulin G (IgG)IBA 12/2021 - 03/2010
7	AntigensIBA 12/2020 - 02/2011
5	ProteomeIBA 01/2021 - 07/2013
5	Phosphopyruvate Hydratase (Enolase)IBA 12/2020 - 09/2011
4	CalciumIBA 01/2021 - 01/2017
4	Blood Proteins (Serum Proteins)IBA 01/2009 - 02/2002
3	Aldehyde Reductase (Aldose Reductase)IBA 12/2020 - 03/2010
3	Complement System Proteins (Complement)IBA 11/2019 - 12/2002
3	Immunoglobulin M (IgM)IBA 10/2019 - 04/2003
3	AntioxidantsIBA 01/2018 - 10/2006
3	Messenger RNA (mRNA)IBA 01/2017 - 10/2006
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2007 - 12/2001
3	NPHS2 proteinIBA 07/2005 - 12/2001
2	Biological ProductsIBA 11/2021 - 01/2021
2	Deoxyribonucleases (DNase)FDA Link 01/2021 - 01/2020
2	AutoantigensIBA 12/2020 - 01/2019
2	Free RadicalsIBA 01/2018 - 10/2006
2	CytokinesIBA 10/2013 - 11/2005
2	Low Density Lipoprotein Receptor-Related Protein-2IBA 04/2012 - 02/2011
2	Serum AlbuminIBA 03/2007 - 10/2006
2	ApolipoproteinsIBA 02/2003 - 01/2001
1	Protein Kinases (Protein Kinase)IBA 06/2022
1	Immune Checkpoint ProteinsIBA 01/2021
1	thymosin beta(4)IBA 01/2021
1	TATA-Box Binding Protein (TATA-Binding Protein)IBA 01/2021
1	SphingomyelinsIBA 01/2021
1	Phospholipase A2 ReceptorsIBA 12/2020
1	ThrombospondinsIBA 12/2020
1	Docosahexaenoic AcidsIBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	methionine sulfoxideIBA 01/2019
1	Tetradecanoylphorbol AcetateIBA 01/2019
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2019
1	Annexin A1IBA 05/2018
1	Peptides (Polypeptides)IBA 05/2018
1	Glutamic Acid (Glutamate)FDA Link 01/2018
1	IronIBA 01/2018
1	Laminin (Merosin)IBA 01/2017
1	Iduronic Acid (Iduronate)IBA 01/2017
1	Oxygen (Dioxygen)IBA 05/2016
1	Adenosine (Adenocard)FDA LinkGeneric 05/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016

Therapy/Procedure

3	Peritoneal Dialysis 05/2022 - 02/2015
3	Therapeutics 10/2019 - 11/2007
3	Plasmapheresis 11/2007 - 12/2001
2	Transplantation 03/2007 - 12/2001
1	Renal Dialysis (Hemodialysis) 05/2022
1	Plasma Exchange 01/2017